• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Relation of coronary heart disease incidence and total mortality to plasma cholesterol reduction in randomised trials: use of meta-analysis.

作者信息

Holme I

机构信息

Life Insurance Companies Institute for Medical Statistics, Oslo, Norway.

出版信息

Br Heart J. 1993 Jan;69(1 Suppl):S42-7. doi: 10.1136/hrt.69.1_suppl.s42.

DOI:10.1136/hrt.69.1_suppl.s42
PMID:8427764
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1025258/
Abstract
摘要

相似文献

1
Relation of coronary heart disease incidence and total mortality to plasma cholesterol reduction in randomised trials: use of meta-analysis.随机试验中冠心病发病率和总死亡率与血浆胆固醇降低的关系：荟萃分析的应用
Br Heart J. 1993 Jan;69(1 Suppl):S42-7. doi: 10.1136/hrt.69.1_suppl.s42.
2
Cholesterol reduction and its impact on coronary artery disease and total mortality.胆固醇降低及其对冠状动脉疾病和总死亡率的影响。
Am J Cardiol. 1995 Sep 28;76(9):10C-17C. doi: 10.1016/s0002-9149(99)80465-2.
3
An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence.一项评估降低胆固醇对总死亡率和冠心病发病率影响的随机试验分析。
Circulation. 1990 Dec;82(6):1916-24. doi: 10.1161/01.cir.82.6.1916.
4
Cholesterol lowering, sudden cardiac death and mortality.降低胆固醇、心源性猝死与死亡率。
Scand Cardiovasc J. 2008 Aug;42(4):264-7. doi: 10.1080/14017430801993206.
5
Lowering cholesterol reduces mortality for heart patients with "normal" lipids.降低胆固醇可降低血脂“正常”的心脏病患者的死亡率。
Harv Heart Lett. 1999 Feb;9(6):5.
6
Cholesterol reduction yields clinical benefits: meta-analysis including recent trials.降低胆固醇可带来临床益处：包括近期试验的荟萃分析
Clin Ther. 2007 May;29(5):778-794. doi: 10.1016/j.clinthera.2007.05.012.
7
Relationship between total mortality and cholesterol reduction as found by meta-regression analysis of randomized cholesterol-lowering trials.通过对随机降胆固醇试验进行Meta回归分析得出的总死亡率与胆固醇降低之间的关系。
Control Clin Trials. 1996 Feb;17(1):13-22. doi: 10.1016/0197-2456(95)00083-6.
8
Five-year trial of clofibrate in ischaemic heart disease.
Br Heart J. 1971 Jan;33(1):145.
9
Statins in the prevention of coronary heart disease.他汀类药物在冠心病预防中的应用
Pharmacotherapy. 1998 Mar-Apr;18(2):242-54.
10
Focusing on high-density lipoprotein for coronary heart disease risk reduction.聚焦于高密度脂蛋白以降低冠心病风险。
Cardiol Clin. 2011 Feb;29(1):105-22. doi: 10.1016/j.ccl.2010.11.005.

引用本文的文献

1
Efficacy of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for prevention of stroke.3-羟基-3-甲基戊二酰辅酶A还原酶抑制剂预防卒中的疗效
J Gen Intern Med. 1999 Dec;14(12):763-74. doi: 10.1046/j.1525-1497.1999.02109.x.
2
Cholesterol lowering diets and coronary heart disease. Advice should now be to increase intake of vegetable oils and fish.降低胆固醇的饮食与冠心病。现在的建议应该是增加植物油和鱼类的摄入量。
BMJ. 1998 Oct 31;317(7167):1253. doi: 10.1136/bmj.317.7167.1253.
3
Does low cholesterol cause death?低胆固醇会导致死亡吗？
Cardiovasc Drugs Ther. 1993 Nov;7(5):789-93. doi: 10.1007/BF00878932.
4
Lowering cholesterol for prevention of coronary heart disease--problems and perspectives.降低胆固醇以预防冠心病——问题与展望
Cardiovasc Drugs Ther. 1993 Nov;7(5):785-8. doi: 10.1007/BF00878931.

本文引用的文献

1
CORN OIL IN TREATMENT OF ISCHAEMIC HEART DISEASE.玉米油在缺血性心脏病治疗中的应用
Br Med J. 1965 Jun 12;1(5449):1531-3. doi: 10.1136/bmj.1.5449.1531.
2
Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men.饮食与吸烟干预对冠心病发病率的影响。奥斯陆健康男性随机试验研究小组的报告。
Lancet. 1981 Dec 12;2(8259):1303-10. doi: 10.1016/s0140-6736(81)91338-6.
3
Sir John Scott Burdon-Sanderson (1828-1905): a pioneer in electrophysiology.约翰·斯科特·伯顿-桑德森爵士（1828 - 1905）：电生理学先驱。
Circulation. 1969 Jul;40(1):1-2. doi: 10.1161/01.cir.40.1.1.
4
Controlled trial of clofibrate in cerebral vascular disease.氯贝丁酯治疗脑血管疾病的对照试验。
Atherosclerosis. 1972 Mar-Apr;15(2):177-83. doi: 10.1016/0021-9150(72)90067-6.
5
Preclinical hypothyroidism: a risk factor for coronary heart-disease.临床前甲状腺功能减退：冠心病的一个危险因素。
Lancet. 1971 Jan 30;1(7692):203-4. doi: 10.1016/s0140-6736(71)90947-0.
6
Multifactorial primary prevention of cardiovascular diseases in middle-aged men. Risk factor changes, incidence, and mortality.
JAMA. 1985 Oct 18;254(15):2097-102.
7
The multifactor primary prevention trial in Göteborg, Sweden.瑞典哥德堡的多因素一级预防试验。
Eur Heart J. 1986 Apr;7(4):279-88. doi: 10.1093/oxfordjournals.eurheartj.a062065.
8
Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.赫尔辛基心脏研究：吉非贝齐用于中年血脂异常男性的一级预防试验。治疗安全性、危险因素变化及冠心病发病率
N Engl J Med. 1987 Nov 12;317(20):1237-45. doi: 10.1056/NEJM198711123172001.
9
An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence.一项评估降低胆固醇对总死亡率和冠心病发病率影响的随机试验分析。
Circulation. 1990 Dec;82(6):1916-24. doi: 10.1161/01.cir.82.6.1916.
10
Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH).部分回肠旁路手术对高胆固醇血症患者冠心病死亡率和发病率的影响。降血脂手术控制项目（POSCH）报告。
N Engl J Med. 1990 Oct 4;323(14):946-55. doi: 10.1056/NEJM199010043231404.